SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-065218
Filing Date
2020-03-06
Accepted
2020-03-06 17:12:10
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d896422ds3.htm S-3 474889
2 EX-1.2 d896422dex12.htm EX-1.2 186208
3 EX-4.5 d896422dex45.htm EX-4.5 283038
4 EX-4.6 d896422dex46.htm EX-4.6 294854
5 EX-5.1 d896422dex51.htm EX-5.1 14403
6 EX-5.2 d896422dex52.htm EX-5.2 7189
7 EX-23.1 d896422dex231.htm EX-23.1 1454
8 GRAPHIC g896422g80x04.jpg GRAPHIC 55508
  Complete submission text file 0001193125-20-065218.txt   1335121
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-236965 | Film No.: 20695759
SIC: 2836 Biological Products, (No Diagnostic Substances)